CHI3L1 and myeloid sarcoma: Interestingly, Schneider et al. reported that elevated levels of CHI3L1 in the CSF of MS patients were correlated with spinal cord atrophy, but elevated NfL levels in the CSF of MS patients were correlated with brain grey matter atrophy, indicating a distinctive pathological pattern associated with each of the mentioned biomarkers [117].